TP53 and squamous cell carcinoma: For example, TP53 mutations are present in 70.4% of squamous cell carcinoma but only in 28% of adenocarcinoma (66, 67) and inflammation has been suggested to increase DNA damage and mutations via generating reactive oxygen species (68).